Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

August 01, 2006 (Vol. 26, No. 14)

Overcoming the Critical Issues in Scale-Up

Improvements in Titer Shift the Bottlenecks Downstream to Purification

  • Mammalian cell products dominate the biopharmaceutical industry and will continue to do so, predicted Andrew Sinclair, managing director of BioPharm Services (www.biopharmservices.com), at this year's "bioLOGIC" conference, held recently in Amsterdam. The top-four product types in clinical trials are monoclonals, cytokines, recombinant proteins, and increasingly, vaccines. Input into ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.